Bernard F Godley, MD, PhD

Dr. Bernard F. Godley is a Senior Client Partner at Korn Ferry, representing the Firm’s Academic Health Center Practice.

Dr. Godley’s research focused on molecular mechanisms of macular degeneration. identifying the genetic locus for progressive bifocal chorioretinal atrophy as a trainee, and, pioneering the study of mitochondrial DNA damage and repair in retinal cells as a contributor to macular degeneration as an NIH-funded investigator. He holds a U.S. patent for a novel noninvasive ocular drug delivery technology. Prior to joining Korn Ferry, Dr. Godley served as Chair of Ophthalmology at the University of Texas Medical Branch for 10 years.